Neidhart, J A <br/><br/>
Minimal single-agent activity of maytansine in refractory breast cancer: a Southwest Oncology Group study.  [electronic resource] 

 -  Cancer treatment reports   
 - 675-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0361-5960 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Breast Neoplasms--drug therapy<br/>Drug Administration Schedule<br/>Drug Evaluation<br/>Drug Resistance<br/>Female<br/>Humans<br/>Maytansine--administration & dosage<br/>Middle Aged<br/>Oxazines--therapeutic use